Arecor share price up after transformative year
Cambridge biopharma company Arecor Therapeutics has earned plaudits from shareholders and a hike in its UK share price after delivering an adept balancing act for the year to December 31.
Rovco appoints Fraser Moonie as new COO as it targets global expansion
Fraser Moonie, a well-known name across the international subsea sector, has been appointed as Chief Operating Officer of Rovco.
Flusso announces major expansion plan
Flusso has announced a major expansion of its Cambridge-based technical team and offices as it ramps up its new flow and gas sensor R&D activities. The investment is the first phase of an ambitious growth plan by the company’s new owners following its acquisition in August last year.
Flow with a flourish as Flusso grows fast
University of Cambridge spin-out Flusso, a fabless semiconductor company in Chinese ownership since last August, has revealed major growth in headcount and workspace.
Arecor appoints experienced deal maker as Chief Business Officer
AIM-listed Arecor Therapeutics plc has appointed Dr Manjit Rahelu as Chief Business Officer with immediate effect, to execute the company’s commercialisation and growth plans.
NoBACZ Healthcare wins £2.7m seed cash for novel wound protection technology
Wound protection specialist, NoBACZ Healthcare – a University of Cambridge spin-out – has secured £2.7 million seed funding.
Forefront RF clinches £6.7m growth capital for fabless chip scale-up
Fabless semiconductor company Forefront RF has raised £6.7 million to support its continued disruption of the global radio frequency market for mobile technologies.
'Mind-blowing': Man turned 'last £200' of student loan into ‘multi-million pound’ business
EXCLUSIVE: Entrepreneur Joe Seddon told Express.co.uk how he launched his business, Zero Gravity, from his childhood bedroom and it's now valued at millions of pounds.
Cambridge investors swoop to Concr in £1.22m seed round
Cambridge investors have piled into a £1.22 million seed round designed to power new biomarker technology being developed for use in oncology by a techbio startup with bases in the UK and Australia.
Legal Spend Management Software Provider Apperio Names Dominic Aelberry as CRO
Customer Success to be a Key Focus of the Newly Created Executive Position; Strategic Hire Builds on Momentum Following a $7 Million Growth Round and Major Business Partnership
Featured interview: Kheiron Medical CEO Dr. Peter Kecskemethy
In the ongoing fight against breast cancer, the American Cancer Society notes that screening mammograms miss around one in eight breast cancers. Now one London-based startup is looking to change that with artificial intelligence. Founded in 2016, Kheiron Medical Technologies is helping radiologists detect breast cancers earlier with its AI screening product. Joining Julia to discuss is Kheiron CEO Dr. Peter Kecskemethy.
Oxford Drug Design and PhoreMost collaborate to advance novel cancer therapeutics discovery
Targeted protein degradation discovery programme to harness artificial intelligence to identify new E3 Ligase-based therapeutic strategies
Dr. David Brown: How Viagra Opened The Doors To Machine Learning Innovation
Throughout his storied career, Dr. David Brown has made significant contributions to medical research within the pharmaceutical industry, but perhaps his most famous innovation came about through a chance observation when the angina medication he was working on had unexpected applications.
OpenAI and Faculty partner to open generative AI use cases
OpenAI, the developer of ChatGPT, has enlisted UK start-up Faculty to help businesses generate new value opportunities with generative AI
East of England women entrepreneurs win Innovate UK awards
Four East of England women entrepreneurs – three of them from Cambridgeshire – have each won Innovate UK Women in Innovation Awards to scale development of novel solutions to major social, environmental and economic challenges.
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification With AI-driven Drug Discovery Platform
Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.
Rarecan eyes up to £3m investment this year as cancer platform targets rapidly growing market
The Hexham-based start-up is on the hunt for a lead investor to take it into its next funding round
Five Alarm Bio raises £500k to strengthen Cambridge’s anti-ageing hand
Cambridge’s hand in the field of anti-ageing science and technology has been strengthened further with a £500k seed investment round for Five Alarm Bio (FAB).
New Featurespace technology zaps the ‘Scamdemic’
The noose has tightened around the necks of online fraudsters after Featurespace unveiled powerful new technology to counter the current Scamdemic – a crippling upsurge in financial crime costing people trillions worldwide.
Arvest Bank launches loan offering leveraging Thought Machine’s solution
US-based Arvest Bank has launched a new credit offering using Thought Machine’s cloud-native core banking technology.